CLINICAL_TRIALS
trial_result
· 2022-07-13
Clinical Trial Update: An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis [Phase 2]
Summary
Phase 2 exploratory maintenance trial of BI 655064 in lupus nephritis has completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-13